VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding VivoSim Labs, INC. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 39 | 44 | +5 |
| Shares | 2.03M | 2.01M | −20.9K (−1.0%) |
| Value | $7.42M | $3.43M | −$3.99M (−53.8%) |
New holders (7)
Institutions that held VivoSim Labs, INC. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Accel Wealth Management | 9,000 | $24.0K | 0.01% |
| Simplex Trading, LLC | 594 | $1.00K | 0.00% |
| Quintet Private Bank (Europe) S.A. | 498 | $842 | 0.00% |
| TD Waterhouse Canada Inc. | 25 | $57 | 0.00% |
| FMR LLC | 18 | $0 | 0.00% |
| Harbour Investments, Inc. | 123 | $0 | 0.00% |
| Toronto Dominion Bank | 44 | $0 | 0.00% |
Sold out (2)
Institutions that held VivoSim Labs, INC. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Bank Julius Baer & Co. Ltd, Zurich | 411 | $2.00K |
| Future Financial Wealth Managment LLC | 25 | $0 |